Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
7.90
+0.52 (7.05%)
At close: Jun 27, 2025, 4:00 PM
8.23
+0.33 (4.18%)
After-hours: Jun 27, 2025, 5:22 PM EDT
Cellectar Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +51.90% | Nov 19, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +77.22% | Oct 11, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +254.43% | Mar 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +51.90% | Mar 28, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +153.16% | Mar 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | -49.37% | Nov 4, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +596.20% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +532.91% | Jul 1, 2020 |
| Maxim Group | Maxim Group | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +279.75% | Jun 23, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +1,165.82% | Jan 21, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +1,292.41% | Sep 13, 2019 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +3,317.72% | Dec 21, 2016 |